Using Ozempic long-term under close monitoring by our doctors at PlushCare can lead to improved health and reduced risks of long-term complications of type 2 diabetes
Survodutide may change that
Its phase 2 obesity trial tested once-weekly doses of 1, 4, 8, and 12 mg, with the higher arms reached through gradual escalation
Design Phase 3, double-blind, randomised, placebo-controlled Duration 72 weeks (20-week titration + 52-week maintenance) Arms Tirzepatide 5 mg, 10 mg, 15 mg, placebo (1:1:1:1) Lifestyle All arms received counselling on diet and physical activity Sponsor Eli Lilly & Company Reference Jastreboff AM et al
2020 Feb;43(2):487493
Set us as preferred When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic